Evidence map›Paper›PMID 31988754›Full record

ArticleJournal of pharmaceutical policy and practice2020

Herbal medicines: a cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults.

Faris El-Dahiyat, Mohamed Rashrash, Sawsan Abuhamdah, Rana Abu Farha, Zaheer-Ud-Din Babar

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The genusHeliyon · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Antioxidant and Antimicrobial Evaluations ofMolecules (Basel, Switzerland) · 2023
    Article
  20. Prospect of herbal medication as prevention against COVID variants.Journal of King Saud University. Science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Faris El-DahiyatCollege of Pharmacy, Al-Ain University, Alain campus, Al-Ain, P. O Box 64141, United Arab Emirates.ORCID 0000-0002-5264-8699
Mohamed Rashrash2Department of Pharmaceutical and Administrative Sciences, School of Pharmacy, University of Charleston, Charleston, WV USA.
Sawsan AbuhamdahCollege of Pharmacy, Al-Ain University, Abu Dhabi campus, Al-Ain, United Arab Emirates.
Rana Abu Farha5Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.
Zaheer-Ud-Din Babar6Department of Pharmacy, University of Huddersfield, Huddersfield, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUnderstanding why adults resort to herbal medicine can help in planning interventions aimed at increasing awareness regarding herbal use. This study sought to investigate the prevalence and to determine factors for predicting the use of herbal medicine among Jordanian adults.

methodsA cross-sectional study was conducted involving 378 older adults who were randomly selected from two different areas of Jordan. A questionnaire was used to gather data and validation criteria for validity and reliability of the content were tested by content and face validity in a panel of experts.

resultsFrom a total of 500 invited participants, 378 completed the questionnaire. The prevalence of the use of of herbal products in this study was high at 80.2%. Herbal medicines use was not associated with any demographic factors other than age (

conclusionThere is a high rate of use of herbal medicines in Jordan, especially among hypertensive patients. Therefore, there is a need to establish effective herbal medicine policies and health education programs to discuss the benefits and risks of herbal medicine use, with the aim of maximizing patient-desired therapeutic outcomes.

Indexed as

AttitudeHerbal medicinesJordanPrevalenceRisk factors

Identifiers

PMID31988754
PMCPMC6971905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.